BioNTech committed to deliver 1.8 bln doses of COVID-19 vaccine this year
The Peninsula
FRANKFURT: BioNTech said on Monday that its order backlog together with partner Pfizer for delivery of COVID-19 vaccines this year had grown to 1.8 billion doses, underscoring its role as a major global supplier of immunization shots.
That was up from 1.4 billion doses announced in March. Based on these delivery contracts, the firm said it expects about 12.4 billion euros ($15.1 billion) in revenues from the product this year, including sales, milestone payments from partners and a share of gross profit in the partners’ territories, up from a previous projection of 9.8 billion euros.More Related News